Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | United States | $18.11M | 64,464,412 | 36.65% | 63.35% | Net Buying | Net Buying |
| INTZ | INTRUSION INC | United States | $8.63M | 4,904,195 | 0.24% | 99.76% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $8.12M | 466,761,105 | 0.64% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $9.96M | 198,386,080 | 1.32% | 0.00% | ||
| BPTH | BIO-PATH HOLDINGS INC | United States | $3.88M | 1,656,235 | 0.11% | 99.89% | ||
| IQ | IQIYI INC | China | $5.56B | 6,716,137,085 | 4.72% | 0.00% | ||
| CLNN | CLENE INC | United States | $49.58M | 128,433,721 | 5.68% | 52.66% | Net Buying | Net Selling |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $9.46M | 53,156,369 | 18.56% | 81.44% | Net Selling | |
| BIOL | BIOLASE INC | United States | $5.31M | 33,394,979 | 1.42% | 55.47% | ||
| LIFE | ATYR PHARMA INC | United States | $133.19M | 69,010,940 | 60.58% | 22.13% | Net Buying | |
| APLM | APOLLOMICS INC | United States | $30.43M | 89,495,790 | 10.33% | 0.00% | ||
| LYRA | LYRA THERAPEUTICS INC | United States | $22.44M | 60,964,859 | 74.71% | 14.19% | Net Buying | |
| GOSS | GOSSAMER BIO INC | United States | $165.14M | 226,218,652 | 85.80% | 14.20% | Net Buying | Net Selling |
| OCUP | OCUPHIRE PHARMA INC | United States | $44.98M | 25,924,158 | 1.12% | 98.88% | Net Buying | Net Buying |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $47.74M | 27,918,560 | 19.44% | 38.25% | ||
| MVST | MICROVAST HOLDINGS INC | United States | $132.91M | 317,196,095 | 20.41% | 31.20% | Net Selling | |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $65.59M | 36,850,279 | 14.58% | 8.97% | Net Selling | Net Selling |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $31.81M | 39,272,434 | 3.50% | 96.50% | Net Buying | Net Selling |
| DARE | DARE BIOSCIENCE INC | United States | $43.98M | 101,092,900 | 6.75% | 25.30% | ||
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.41M | 16,309,393 | 6.21% | 65.32% | Net Buying | |
| SYBX | SYNLOGIC INC | United States | $19.67M | 11,707,011 | 5.74% | 94.26% | Net Selling | Net Selling |
| FEMY | FEMASYS INC | United States | $28.66M | 22,220,718 | 6.63% | 8.01% | ||
| IMRX | IMMUNEERING CORP | United States | $45.67M | 29,653,355 | 40.03% | 46.80% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $97.19M | 26,996,740 | 22.29% | 5.19% | Net Selling | Net Selling |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $93.21M | 53,260,467 | 58.83% | 24.11% | ||
| LUMO | LUMOS PHARMA INC | United States | $21.35M | 8,116,488 | 16.51% | 83.49% | Net Buying | Net Buying |
| GOEV | CANOO INC | United States | $196.79M | 68,567,495 | 6.24% | 93.76% | Net Buying | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $12.32M | 50,924,284 | 5.27% | 34.31% | Net Selling | Net Buying |
| INAB | IN8BIO INC | United States | $45.01M | 44,123,949 | 19.55% | 51.06% | Net Buying | |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $6.88M | 16,008,469 | 10.40% | 46.72% | Net Buying | |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $71.41M | 54,933,774 | 81.92% | 18.08% | Net Buying | Net Buying |
| GEVO | GEVO INC | United States | $166.54M | 236,232,717 | 29.44% | 11.14% | Net Selling | |
| PRST | PRESTO AUTOMATION INC | United States | $13.17M | 80,791,967 | 8.37% | 68.69% | Net Buying | |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.76M | 3,112,401 | 1.08% | 98.92% | Net Buying | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $71.54M | 22,217,265 | 3.46% | 96.54% | ||
| CARA | CARA THERAPEUTICS INC | United States | $44.01M | 54,675,954 | 43.18% | 53.39% | Net Selling | Net Selling |
| AMPX | AMPRIUS TECHNOLOGIES INC | United States | $122.81M | 94,472,655 | 5.22% | 75.78% | Net Selling | Net Buying |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $146.94M | 208,127,550 | 39.64% | 13.96% | Net Selling | Net Buying |
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.84% | 0.00% | ||
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $171.56M | 23,405,637 | 3.76% | 96.24% | Net Buying | Net Buying |
| ACET | ADICET BIO INC | United States | $129.01M | 82,173,503 | 82.35% | 17.65% | Net Buying | |
| FBIO | FORTRESS BIOTECH INC | United States | $35.05M | 19,916,124 | 14.56% | 60.54% | Net Buying | Net Buying |
| TARA | PROTARA THERAPEUTICS INC | United States | $77.01M | 20,589,976 | 12.52% | 87.48% | Net Selling | Net Selling |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $31.69M | 41,154,799 | 43.66% | 44.89% | Net Selling | Net Selling |
| MBRX | MOLECULIN BIOTECH INC | United States | $11.63M | 2,311,536 | 4.04% | 95.96% | Net Buying | |
| VOR | VOR BIOPHARMA INC | United States | $122.87M | 68,259,602 | 86.36% | 10.15% | Net Selling | Net Selling |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $546.36M | 68,380,857 | 40.09% | 50.20% | Net Selling | Net Selling |
| AQMS | AQUA METALS INC | United States | $49.48M | 113,226,006 | 18.77% | 15.25% | Net Selling | |
| IKNA | IKENA ONCOLOGY INC | United States | $67.56M | 48,258,111 | 61.82% | 18.22% | ||
| NTBL | NOTABLE LABS LTD | Israel | $9.38M | 9,018,261 | 2.95% | 97.05% | Net Selling | |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $151.59M | 31,913,887 | 51.04% | 48.96% | Net Buying | Net Buying |
| AGEN | AGENUS INC | United States | $220.49M | 20,999,261 | 60.95% | 39.05% | Net Buying | Net Buying |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $12.37M | 284,379,960 | 0.94% | 5.95% | ||
| PGEN | PRECIGEN INC | United States | $353.39M | 252,419,690 | 24.41% | 72.43% | Net Buying | Net Selling |
| SBEV | SPLASH BEVERAGE GROUP INC | United States | $13.30M | 47,656,088 | 6.10% | 2.91% | Net Buying | |
| IPA | IMMUNOPRECISE ANTIBODIES LTD | Canada | $29.47M | 26,315,260 | 6.36% | 0.00% | ||
| HOOK | HOOKIPA PHARMA INC | United States | $80.25M | 98,950,107 | 36.20% | 26.83% | Net Buying | |
| LCTX | LINEAGE CELL THERAPEUTICS INC | United States | $200.13M | 188,798,145 | 39.25% | 60.75% | Net Buying | |
| IVA | INVENTIVA SA | France | $190.33M | 52,115,807 | 9.29% | 0.00% | ||
| CDTX | CIDARA THERAPEUTICS INC | United States | $54.74M | 4,561,708 | 60.41% | 39.59% | Net Selling | Net Selling |
| GRTS | GRITSTONE BIO INC | United States | $81.10M | 108,569,374 | 43.16% | 20.10% | Net Buying | |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $119.38M | 35,848,924 | 25.47% | 11.43% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.